Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Adv Healthc Mater ; 5(14): 1786-99, 2016 07.
Artículo en Inglés | MEDLINE | ID: mdl-27253638

RESUMEN

Antisense oligodeoxynucleotides targeting the mRNA of the gap junction protein Cx43 promote tissue repair in a variety of different wounds. Delivery of the antisense drug has most often been achieved by a thermoreversible hydrogel, Pluronic F-127, which is very effective in the short term but does not allow for sustained delivery over several days. For chronic wounds that take a long time to heal, repeated dosing with the drug may be desirable but is not always compatible with conventional treatments such as the weekly changing of compression bandages on venous leg ulcers. Here the coating of collagen scaffolds with antisense oligonucleotides is investigated and a way to provide protection of the oligodeoxynucleotide drug is found in conjunction with sustained release over a 7 d period. This approach significantly reduces the normal foreign body reaction to the scaffold, which induces an increase of Cx43 protein and an inhibition of healing. As a result of the antisense integration into the scaffold, inflammation is reduced with the rate of wound healing and contracture is significantly improved. This coated scaffold approach may be very useful for treating venous leg ulcers and also for providing a sustained release of any other types of oligonucleotide drugs that are being developed.


Asunto(s)
Materiales Biocompatibles Revestidos/química , Colágeno/química , Conexina 43 , Oligodesoxirribonucleótidos Antisentido , Andamios del Tejido/química , Cicatrización de Heridas/efectos de los fármacos , Heridas y Lesiones/terapia , Animales , Preparaciones de Acción Retardada/química , Preparaciones de Acción Retardada/farmacocinética , Preparaciones de Acción Retardada/farmacología , Hidrogeles/química , Hidrogeles/farmacocinética , Hidrogeles/farmacología , Oligodesoxirribonucleótidos Antisentido/química , Oligodesoxirribonucleótidos Antisentido/farmacocinética , Oligodesoxirribonucleótidos Antisentido/farmacología , Poloxámero/química , Poloxámero/farmacocinética , Poloxámero/farmacología , Ratas , Ratas Sprague-Dawley , Heridas y Lesiones/metabolismo , Heridas y Lesiones/patología
2.
Adv Healthc Mater ; 2(8): 1151-60, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23417927

RESUMEN

Scaffolds have been reported to promote healing of hard-to-heal wounds such as burns and chronic ulcers. However, there has been little investigation into the cell biology of wound edge tissues in response to the scaffolds. Here, we assess the impact of collagen scaffolds on mouse full-thickness wound re-epithelialisation during the first 5 days of healing. We find that scaffolds impede wound re-epithelialisation, inducing a bulbous thickening of the wound edge epidermis as opposed to the thin tongue of migratory keratinocytes seen in normal wound healing. Scaffolds also increase the inflammatory response and the numbers of neutrophils in and around the wound. These effects were also produced by scaffolds made of alginate in the form of fibers and microspheres, but not as an alginate hydrogel. In addition, we find the gap junction protein connexin 43, which normally down-regulates at the wound edge during re-epithelialisation, to be up-regulated in the bulbous epidermal wound edge. Incorporation of connexin 43 antisense oligodeoxynucleotides into the scaffold can be performed to reduce inflammation whilst promoting scaffold biocompatibility.


Asunto(s)
Conexina 43/metabolismo , Oligodesoxirribonucleótidos Antisentido/farmacología , Piel/patología , Andamios del Tejido , Cicatrización de Heridas/efectos de los fármacos , Alginatos/química , Animales , Movimiento Celular , Colágeno/química , Conexina 43/antagonistas & inhibidores , Conexina 43/genética , Ácido Glucurónico/química , Ácidos Hexurónicos/química , Queratinocitos/citología , Masculino , Ratones , Ratones Endogámicos ICR , Microesferas , Oligodesoxirribonucleótidos Antisentido/química , Polímeros/química , Piel/lesiones
3.
Cell Biol Int ; 36(7): 661-7, 2012 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-22455314

RESUMEN

Poor healing of DFUs (diabetic foot ulcers) is a major clinical problem that can be extremely debilitating and lead to lower limb amputation. In the normal acute wound, the Cx43 (connexin 43) gap junction protein is down-regulated at the wound edge as a precursor to cell migration and healing. In fibroblasts from the human chronic DFU wound edge there was a striking and significant 10-fold elevation of Cx43 protein, as well as a 6-fold increase in N-cadherin and a 2-fold increase in ZO-1 (zonular occludin-1), compared with unwounded skin. In streptozotocin diabetic rats, Cx43 was found to be up-regulated in intact dermal fibroblasts in direct proportion to blood glucose levels and increased 2-fold further in response to wounding of the skin. To mimic diabetes, NIH 3T3 fibroblasts were cultured under different concentrations of glucose or mannitol and Cx43 protein intercellular communication and migration rates were determined. Cultures of fibroblasts in very high (40 mM) glucose conditions showed significantly elevated Cx43 protein levels, as shown by immunostaining and Western blotting, and significantly increasing gap junctional communication, as shown by dye transfer. In scratch wound-healing assays, increased levels of Cx43 from high glucose resulted in repressed filopodial extensions and significantly slower migration rates than in either standard conditions (5.5 mM glucose) or the osmotic control of mannitol. Conversely, when glucose-induced Cx43 up-regulation was prevented with Cx43shRNA (Cx43 short-hairpin RNA) transduction, the fibroblasts extended long filopodia and migrated significantly faster. Cx43 protein was up-regulated in fibroblasts in DFUs as well as after high glucose exposure in culture which correlated with inhibition of fibroblast migration and is likely to contribute to impaired wound healing.


Asunto(s)
Movimiento Celular/efectos de los fármacos , Conexina 43/metabolismo , Pie Diabético/metabolismo , Fibroblastos/citología , Animales , Cadherinas/metabolismo , Conexina 43/antagonistas & inhibidores , Conexina 43/genética , Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Experimental/patología , Pie Diabético/patología , Fibroblastos/metabolismo , Glucosa/farmacología , Humanos , Masculino , Manitol/farmacología , Proteínas de la Membrana/metabolismo , Ratones , Células 3T3 NIH , Fosfoproteínas/metabolismo , Interferencia de ARN , ARN Interferente Pequeño/metabolismo , Ratas , Ratas Sprague-Dawley , Regulación hacia Arriba/efectos de los fármacos , Proteína de la Zonula Occludens-1
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA